We are live on ! Find out more
SAM

Senzar Asset Management Portfolio holdings

AUM $34.7M
1-Year Est. Return 0.56%
This Fund
S&P 500
This Quarter Est. Return
-2.83%
1 Year Est. Return
+0.56%
3 Year Est. Return
-0.75%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$377M
AUM Growth
-$9.7M
Cap. Flow
-$133K
Cap. Flow %
-0.04%
Top 10 Hldgs %
73.26%
Holding
43
New
8
Increased
13
Reduced
9
Closed
13

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$20.8M
2
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
+$18.1M
3
ESRX
Express Scripts Holding Company
ESRX
+$10.7M
4
SHPG
Shire pic
SHPG
+$10.4M
5
TVTY
Tivity Health, Inc. Common Stock
TVTY
+$9.02M

Top Sells

Rank Stock Value
1
AET
Aetna Inc
AET
+$14.3M
2
ELGX
Endologix Inc
ELGX
+$13.9M
3
ENTA icon
Enanta Pharmaceuticals
ENTA
+$13.5M
4
BHC icon
Bausch Health
BHC
+$12M
5
MOH icon
Molina Healthcare
MOH
+$10.5M

Sector Composition

Rank Sector Weight
1 Healthcare 97.01%
2 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SNY icon
1
Sanofi
SNY
$105B
$49.9M 13.24%
1,234,200
-200,400
-14% -$7.9M
LLY icon
2
Eli Lilly
LLY
$1.04T
$40.3M 10.68%
547,405
+112,905
+26% +$8.41M
SHPG
3
DELISTED
Shire pic
SHPG
$33.5M 8.87%
196,400
+58,500
+42% +$10.4M
AGN
4
DELISTED
Allergan plc
AGN
$33.3M 8.84%
158,700
+100,200
+171% +$20.8M
ELV icon
5
Elevance Health
ELV
$84.4B
$31M 8.22%
215,500
-3,700
-2% -$495K
ESRX
6
DELISTED
Express Scripts Holding Company
ESRX
$30.7M 8.15%
447,001
+149,301
+50% +$10.7M
TSRO
7
DELISTED
TESARO, Inc.
TSRO
$19.1M 5.07%
142,300
+58,000
+69% +$7.32M
MNK
8
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$15.3M 4.05%
+306,500
New +$18.1M
HALO icon
9
Halozyme
HALO
$9.23B
$12.1M 3.21%
1,225,444
+674,900
+123% +$7.39M
MDXG icon
10
MiMedx Group
MDXG
$621M
$11M 2.93%
1,245,550
-292,906
-19% -$2.63M
TVTX icon
11
Travere Therapeutics
TVTX
$5.24B
$9.33M 2.47%
492,889
+22,100
+5% +$452K
TVTY
12
DELISTED
Tivity Health, Inc. Common Stock
TVTY
$8.72M 2.31%
+383,200
New +$9.02M
CNC icon
13
Centene
CNC
$32.6B
$8.28M 2.2%
+293,200
New +$8.65M
MYGN icon
14
Myriad Genetics
MYGN
$536M
$8.25M 2.19%
+495,100
New +$8.96M
MNTA
15
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$8.01M 2.12%
531,898
-430,200
-45% -$5.68M
ABT icon
16
Abbott
ABT
$175B
$7.54M 2%
+196,300
New +$7.78M
AERI
17
DELISTED
Aerie Pharmaceuticals
AERI
$7.15M 1.9%
188,900
+96,700
+105% +$3.66M
CORI
18
DELISTED
Corium International, Inc.
CORI
$6.4M 1.7%
1,576,766
-26,300
-2% -$131K
FOMX
19
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$6.12M 1.62%
550,997
+27,600
+5% +$260K
ESPR
20
DELISTED
Esperion Therapeutics
ESPR
$4.56M 1.21%
+364,000
New +$4.33M
NDRM
21
DELISTED
NeuroDerm Ltd. Ordinary Shares
NDRM
$4.15M 1.1%
186,800
+15,500
+9% +$290K
CNCE
22
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$4.12M 1.09%
400,588
-171,800
-30% -$1.57M
OFIX icon
23
Orthofix Medical
OFIX
$447M
$4.03M 1.07%
+111,375
New +$4.23M
ARNA
24
DELISTED
Arena Pharmaceuticals Inc
ARNA
$2.67M 0.71%
187,749
+23,960
+15% +$371K
ALDR
25
DELISTED
Alder Biopharmaceuticals
ALDR
$2.59M 0.69%
124,570
-172,100
-58% -$4.48M
1
2

Similar funds

BCP
Blum Capital Partners San Francisco, California $34.1M AUM 1.14% 1-Year Est. Return
PRHC
P.R. Herzig & Co Roslyn Heights, New York $45.9M AUM 15.88% 1-Year Est. Return
NAM
Needelman Asset Management Ladera Ranch, California $46M AUM 8.27% 1-Year Est. Return
GG
Gores Group Beverly Hills, California $22.3M AUM 4.58% 1-Year Est. Return
SM
SLS Management New York $17.2M AUM 14.82% 1-Year Est. Return
BC
Breogan Capital New York $56.4M AUM
SCPM
Social Capital PEP Management Palo Alto, California $56.5M AUM
FAM
Fortaleza Asset Management Chicago, Illinois $12.3M AUM 48.33% 1-Year Est. Return

Senzar Asset Management's Q4 2016 Portfolio in Review

As of Q4 2016, Senzar Asset Management held 43 positions worth $377M, down 2.5% from $387M the previous quarter. Its ten largest holdings account for 73% of the portfolio.

Senzar Asset Management's Q4 2016 filing shows 8 new, 13 increased, 9 reduced and 13 closed positions. Its largest new stake was MALLINCKRODT PUBLIC LIMITED COMPANY: 306,500 shares worth $15.3M. The largest sale was Aetna Inc, an estimated $14.3M.

By sector, the portfolio is most concentrated in Healthcare at 97% of assets, up from 90% a quarter earlier, followed by Financials.

  • Senzar Asset Management's largest Q4 2016 buy was MALLINCKRODT PUBLIC LIMITED COMPANY: 306,500 shares worth $15.3M.
  • Senzar Asset Management added most to Allergan plc in Q4 2016, an estimated $20.8M increase.
  • Senzar Asset Management's biggest Q4 2016 reduction was Sanofi, cutting an estimated $7.9M.
  • Senzar Asset Management fully exited Aetna Inc in Q4 2016, selling an estimated $14.3M.
  • Senzar Asset Management's ten largest holdings make up 73% of its $377M portfolio in Q4 2016.
  • Senzar Asset Management opened 8 new positions and closed 13 in Q4 2016.
  • Senzar Asset Management's portfolio value fell 2.5% quarter-over-quarter to $377M.

Based on Senzar Asset Management's 13F filing for Q4 2016, filed 14 Feb 2017.